Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $110.82 | 2 | 50.8% |
| Food and Beverage | $107.51 | 6 | 49.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Epizyme, Inc., | $99.75 | 1 | $0 (2021) |
| Genentech USA, Inc. | $55.29 | 3 | $0 (2018) |
| Astellas Pharma US Inc | $24.88 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $21.79 | 2 | $0 (2021) |
| PFIZER INC. | $16.62 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $110.82 | 2 | Epizyme, Inc., ($99.75) |
| 2019 | $41.50 | 2 | Astellas Pharma US Inc ($24.88) |
| 2018 | $36.56 | 2 | Genentech USA, Inc. ($36.56) |
| 2017 | $29.45 | 2 | Genentech USA, Inc. ($18.73) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2021 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Education | In-kind items and services | $11.07 | General |
| Category: Hematology | ||||||
| 07/20/2021 | Epizyme, Inc., | TAZVERIK (Drug) | Education | In-kind items and services | $99.75 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2019 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: ONCOLOGY | ||||||
| 05/29/2019 | Astellas Pharma US Inc | XOSPATA (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2018 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: BioOncology | ||||||
| 08/01/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: BioOncology | ||||||
| 08/24/2017 | Genentech USA, Inc. | Herceptin (Biological), Perjeta | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: BioOncology | ||||||
| 03/28/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $10.72 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 186 | 384 | $101,622 | $31,270 |
| 2022 | 5 | 188 | 376 | $93,500 | $31,893 |
| 2021 | 5 | 205 | 445 | $110,529 | $39,720 |
| 2020 | 6 | 222 | 399 | $94,760 | $31,365 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 119 | 275 | $64,195 | $19,829 | 30.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 58 | $18,865 | $5,549 | 29.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 22 | 22 | $9,762 | $3,125 | 32.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $7,092 | $2,510 | 35.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 11 | 11 | $1,708 | $256.77 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 127 | 293 | $65,685 | $22,880 | 34.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 25 | 25 | $10,678 | $3,754 | 35.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 35 | $10,949 | $2,897 | 26.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $4,141 | $1,761 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 12 | $2,047 | $602.43 | 29.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 116 | 293 | $63,084 | $23,874 | 37.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 84 | $25,032 | $7,125 | 28.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 33 | 33 | $13,519 | $5,039 | 37.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $5,741 | $2,620 | 45.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 17 | 19 | $3,153 | $1,062 | 33.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 114 | 243 | $50,103 | $15,596 | 31.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 21 | 66 | $18,912 | $5,760 | 30.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 32 | 32 | $12,544 | $4,416 | 35.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 25 | $8,592 | $4,225 | 49.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 17 | 19 | $3,013 | $815.08 | 27.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 14 | 14 | $1,596 | $552.30 | 34.6% |
About Dr. Bharti Rathore, MD
Dr. Bharti Rathore, MD is a Hematology & Oncology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821043795.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bharti Rathore, MD has received a total of $218.33 in payments from pharmaceutical and medical device companies, with $110.82 received in 2021. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Education" ($110.82).
As a Medicare-enrolled provider, Rathore has provided services to 801 Medicare beneficiaries, totaling 1,604 services with total Medicare billing of $134,248. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Providence, RI
- Active Since 05/22/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1821043795
Products in Payments
- TAZVERIK (Drug) $99.75
- XOSPATA (Drug) $24.88
- Avastin (Biological) $19.86
- Herceptin (Biological) $18.73
- Alecensa (Biological) $16.70
- IBRANCE (Drug) $16.62
- Pomalyst (Drug) $11.07
- OPDIVO (Biological) $10.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Providence
Ritesh Rathore, Md, MD
Hematology & Oncology — Payments: $324,296
Anthony Mega, Md, MD
Hematology & Oncology — Payments: $193,307
Dr. Adam Olszewski, M.d, M.D
Hematology & Oncology — Payments: $47,507
John Reagan, Md, MD
Hematology & Oncology — Payments: $35,520
Hina Khan, M.d, M.D
Hematology & Oncology — Payments: $19,225
Dr. Joseph Dibenedetto, Md, MD
Hematology & Oncology — Payments: $6,205